Sujit Basu, MD, PhD
Academic Title: Professor in the College of Medicine
Research Program: Translational Therapeutics
About Me
More info forI am a member of the Translational Therapeutics Program at the OSUCCC – James, where my research explores the role of endogenous factors regulating tumor microenvironment, including tumor neovascularization and the development of new therapies.
One of my recent studies indicates that dopamine may be used safely as an antiangiogenic drug to treat malignant tumors.
I have co-authored numerous articles in well-respected publications, such as Nature Medicine, Journal of Clinical Investigation, PNAS and Cancer Research.
Research Interests
More info for- Stem Cells
- Stomach Neoplasms
- Skin Neoplasms
- Therapeutics
- Tumor Microenvironment
- Colonic Neoplasms
- Wounds and Injuries
Academic Office & Contact Information
More info forAcademic Office:
Evans Hall 0250
520 King Ave
Columbus, Ohio 43201Phone:
614-247-5414Email:
basu.27@osu.eduPublications
More info forJuly 8, 2024IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10.
Liu JQ, Jabbari A, Lin CH, Akkanapally V, Frankel WL, Basu S, He K, Zheng P, Liu Y, Bai XF
Journal of Immunology
January 28, 2024Therapeutic Immunomodulation in Gastric Cancer.
Akkanapally V, Bai XF, Basu S
Cancers (Basel)
June 16, 2023CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cells.
Lin CH, Talebian F, Yang L, Zhu J, Liu JQ, Zhao B, Basu S, Pan X, Chen X, Yan P, Carson WE, Xin G, Wen H, Wang R, Li Z, Ma Q, Bai XF
iScience
July 28, 2022Neuropeptide Y, a paracrine factor secreted by cancer cells, is an independent regulator of angiogenesis in colon cancer.
Chakroborty D, Goswami S, Fan H, Frankel WL, Basu S, Sarkar C
Br J Cancer
June 1, 2022VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cells.
Sarkar C, Chakroborty D, Goswami S, Fan H, Mo X, Basu S
J Cell Sci
April 12, 2021Dopamine prevents ultraviolet B-induced development and progression of premalignant cutaneous lesions through its D2 receptors.
Lu K, Bhat M, Peters S, Mitra R, Mo X, Oberyszyn TM, Dasgupta PS, Basu S
Cancer Prev Res (Phila)
January 22, 2021Suppression of beta 2 adrenergic receptor actions prevent UVB mediated cutaneous squamous cell tumorigenesis through inhibition of VEGF-A induced angiogenesis.
Lu K, Bhat M, Peters S, Mitra R, Oberyszyn T, Basu S
Mol Carcinog
August 23, 2020Angiogenesis Inhibition in Prostate Cancer: An Update.
Sarkar C, Goswami S, Basu S, Chakroborty D
Cancers (Basel)